GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage ...

On Friday, February 14, the FDA approved GSK plc’s (NYSE:GSK) Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for use in individuals aged 10 through 25. The vaccine targets five major ...

The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for acti ...

Adult and pediatric patients who received 2023-2024 influenza vaccines exhibited reduced risk for influenza-associated encounters across care settings.

Kate O'Brien, Director of the Department of Immunization, Vaccines and Biologicals at WHO Safeguarding children and ...

The new study is the largest yet to test whether there’s a link between child development and COVID vaccination or infection ...

West Texas is experiencing its worst measles outbreak in nearly 30 years, with 48 cases mainly in unvaccinated children.

The United Nations Children's Fund and GAVI, the international vaccination group on Tuesday handed over a primary healthcare ...

The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...

Updated Hep B Vaccine More Effective for People With ... Improving HIV Treatment in Children and Adolescents -- The Right Way July 18, 2024 — Globally, around 2.6 million children and ...